Literature DB >> 1826264

Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts.

C Estaller1, W Schwaeble, M Dierich, E H Weiss.   

Abstract

The human complement factor H is an important component in the control of the alternative pathway of complement activation. We have previously shown that a least three factor H homologous mRNA species of 4.3 kb, 1.8 kb and 1.4 kb in length are constitutively expressed in human liver. In addition, several factor H-related proteins have been detected in human sera using antibodies directed against the classical human factor H glycoprotein of 150 kDa. The structure of the additional polypeptides has not been shown so far. Circumstantial evidence suggests that the 1.8-kb mRNA might encode the 43-kDa factor H-like polypeptide. Here we report the isolation, characterization and eukaryotic expression of the first full-length cDNA representing the major 4.3-kb mRNA and the 1.8-kb mRNA of human factor H. We show that the 4.3-kb transcript encodes the 150-kDa-factor H glycoprotein and the 1.8-kb mRNA the 43-kDa factor H polypeptide. The identity of the two cDNA in a region of 1400 nucleotides suggests that the two factor H-related transcripts are derived from one gene by a process of alternative splicing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826264     DOI: 10.1002/eji.1830210337

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  Polymorphism and deficiency of human factor H-related proteins p39 and p37.

Authors:  E Feifel; W M Prodinger; M Mölgg; W Schwaeble; D Schönitzer; V Koistinen; R Misasi; M P Dierich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins.

Authors:  W M Prodinger; J Hellwage; M Spruth; M P Dierich; P F Zipfel
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 3.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

4.  Two factor H-related proteins from the mouse: expression analysis and functional characterization.

Authors:  Jens Hellwage; Florian Eberle; Tanja Babuke; Harald Seeberger; Heiko Richter; Anja Kunert; Albert Härtl; Peter F Zipfel; T Sakari Jokiranta; Mihály Józsi
Journal:  Immunogenetics       Date:  2006-10-07       Impact factor: 2.846

5.  Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes.

Authors:  Lin Wei; Vinod Pandiripally; Eugene Gregory; Micaya Clymer; David Cue
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.

Authors:  Vinod Pandiripally; Eugene Gregory; David Cue
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 7.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

8.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.

Authors:  A K Sharma; M K Pangburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

Authors:  A Steinkasserer; C Estaller; E H Weiss; R B Sim; A J Day
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

10.  Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci.

Authors:  Vinod Pandiripally; Lin Wei; Christine Skerka; Peter F Zipfel; David Cue
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.